Salarius Pharmaceuticals Statistics
Total Valuation
SLRX has a market cap or net worth of $1.22 million. The enterprise value is -$896,382.
Important Dates
The last earnings date was Monday, March 24, 2025, before market open.
| Earnings Date | Mar 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SLRX has 1.75 million shares outstanding. The number of shares has increased by 135.79% in one year.
| Current Share Class | 1.75M |
| Shares Outstanding | 1.75M |
| Shares Change (YoY) | +135.79% |
| Shares Change (QoQ) | +12.70% |
| Owned by Insiders (%) | 2.08% |
| Owned by Institutions (%) | 5.29% |
| Float | 1.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.72 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.98 |
| Quick Ratio | 1.61 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -164.02% and return on invested capital (ROIC) is -98.05%.
| Return on Equity (ROE) | -164.02% |
| Return on Assets (ROA) | -74.59% |
| Return on Invested Capital (ROIC) | -98.05% |
| Return on Capital Employed (ROCE) | -379.33% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.79M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.44% in the last 52 weeks. The beta is 0.55, so SLRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -83.44% |
| 50-Day Moving Average | 1.47 |
| 200-Day Moving Average | 1.77 |
| Relative Strength Index (RSI) | 29.15 |
| Average Volume (20 Days) | 378,202 |
Short Selling Information
The latest short interest is 40,435, so 2.32% of the outstanding shares have been sold short.
| Short Interest | 40,435 |
| Short Previous Month | 85,721 |
| Short % of Shares Out | 2.32% |
| Short % of Float | 2.37% |
| Short Ratio (days to cover) | 0.22 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.73M |
| Pretax Income | -6.46M |
| Net Income | -5.58M |
| EBITDA | -5.73M |
| EBIT | -5.73M |
| Earnings Per Share (EPS) | -$5.79 |
Full Income StatementBalance Sheet
The company has $2.43 million in cash and $221,866 in debt, giving a net cash position of $2.21 million or $1.27 per share.
| Cash & Cash Equivalents | 2.43M |
| Total Debt | 221,866 |
| Net Cash | 2.21M |
| Net Cash Per Share | $1.27 |
| Equity (Book Value) | 1.51M |
| Book Value Per Share | 1.05 |
| Working Capital | 1.48M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.53M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.53M |
| FCF Per Share | -$2.59 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |